MAY J A, STIMMEL B F
Calif Med. 1955 Mar;82(3):171-5.
In studies of men's capacity for estrogen inactivation in health and disease, it was observed that patients with prostatic cancer had enhanced ability to inactivate estrogenic hormones. This ability might well lead to excessive androgen stimulation, thereby providing favorable hormonal environment for the development of prostatic cancer. Extension or regression of the malignant process did not affect this peculiar pattern of estrogen metabolism. It is possible, therefore, that the pattern may not be related to the cancer process itself but to some inherent tendency in the individual. Upon speculation as to whether or not this tendency is found in the liver, which is known to be the principal site of estrogen inactivation, studies of patients with liver damage were carried out and the results indicated that the liver possesses a tremendous reserve for inactivation of the estrogens in men. Studies on estrogen concentration in the bile indicated that estrogens are not eliminated rapidly from the human body through the biliary tract. However, this does not hold true for experimental animals. Observations on endogenous estrogen excretion in men did not support the concept that benign prostatic hypertrophy is due to an elevated estrogen-androgen ratio.
在关于男性在健康和疾病状态下雌激素灭活能力的研究中,观察到前列腺癌患者灭活雌激素的能力增强。这种能力很可能导致雄激素过度刺激,从而为前列腺癌的发展提供有利的激素环境。恶性进程的进展或消退并不影响这种独特的雌激素代谢模式。因此,这种模式可能与癌症进程本身无关,而是与个体的某些内在倾向有关。在推测这种倾向是否存在于已知为雌激素灭活主要部位的肝脏中时,对肝损伤患者进行了研究,结果表明肝脏对男性体内雌激素的灭活具有巨大的储备能力。对胆汁中雌激素浓度的研究表明,雌激素不会通过胆道迅速从人体排出。然而,实验动物的情况并非如此。对男性内源性雌激素排泄的观察并不支持良性前列腺增生是由于雌激素与雄激素比例升高这一观点。